How is Zimmer Biomet (ZBH) doing?
Zimmer Biomet is a company in the medical, devices industry, based in Warsaw, IN, worth $17.2B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.
Updated Oct 9, 2026
Weak
Zimmer Biomet shares are down 9% over the past year, 22 points behind the S&P 500. Its type is Turning Up. Among large US stocks and funds it ranks in the 25th percentile on market beat, the 4th on staying power and the 60th on business growth. It appears on 3 of our dashboards.
Compare with SYK · MDT · JNJ · GMED
Financials, earnings and news on Stox ›The past year
Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.
What kind of stock is it?
Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.
Turning Up
Lagging and erratic, but the business is growing and buyers are arriving.
Turning Up this month; Bottom Fished before that.
Also Turning Up (51 in all): EHC · RMD · ISRG · MSA · PPG · SF
How is it doing against its group?
Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.
Zimmer Biomet is −9% over the past year, against +21% for the rest of the group and +16% for the S&P 500. It ranks 65th of 86 in Health care.
How much does it move?
Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.
About usual Zimmer Biomet typically moves 2.7% in a day, about usual for it, and it swings less than 63% of large US stocks.
ZBH on our dashboards
Every question where Zimmer Biomet appears, in the order of the home page, with its reading and place in that table. Select a question to open it with ZBH highlighted. Select a column to sort.
| Question | Reading | Place | Details |
|---|---|---|---|
| Who is spending big on expansion? Business quality | 95Ramping | 17 of 60 | Capex, 1Y +97% · A year $470.2M · % of revenue 6% |
| Which stocks are cheapest on cash flow? Value | 95Cheap | 38 of 60 | Cash yield 10.3% · Price / FCF 9.7× · Cash margin 22% |
| Which stocks trade below book value? Value | 89Near book | 51 of 60 | P/B 1.41x · Return on equity +6% · Book value $12.6B |
Go deeper on Stox
ZBH’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.
How to read this page
How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.
Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.
Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.
Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.
Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.
For financial statements, earnings and news, see ZBH’s full profile on Stox.
This page is information, not investment advice. About our data and methods ›